Background Pancreatic cancer is an insidious and heterogeneous malignancy with poor
prognosis that is often locally unresectable. Therefore, determining the underlying …

Pancreatic adenocarcinoma (PAAD) is a pancreatic disease with considerable mortality
worldwide. Because of a lack of obvious symptoms at the early stage, most PAAD patients …

Background It is well acknowledged that cancer-related pathways play pivotal roles in the
progression of pancreatic cancer (PC). Employing Integrated analysis, we aim to identify the …

Background Pancreatic adenocarcinoma is one of the most lethal tumors in the world with a
poor prognosis. Thus, an accurate prediction model, which identify patients within high risk …

Background Emerging evidence suggests that competing endogenous RNAs plays a crucial
role in the development and progress of pancreatic adenocarcinoma (PAAD). The objective …

Pancreatic adenocarcinoma (PAAD) is characterized by high malignancy, frequent
metastasis, and recurrence with an unfavorable prognosis. This study is aimed at …

Background and aim Pancreatic cancer (PC) is one of the most common tumors with a poor
prognosis. The current American Joint Committee on Cancer (AJCC) staging system, based …

Background: Pancreatic cancer is highly lethal and aggressive with increasing trend of
mortality in both genders. An effective prediction model is needed to assess prognosis of …

Pancreatic cancer (PC) is one of the most lethal malignancies with an extremely poor
prognosis. In this study, we aim to construct a long noncoding RNA (lncRNA)-based panel …

Background Although some improvements in the management of pancreatic cancer (PC)
have been made, no major breakthroughs in terms of biomarker discovery or effective …